| Symbol |
Name |
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ATF2
|
activating transcription factor 2
|
|
ATM
|
ATM serine/threonine kinase
|
|
BACH2
|
BTB and CNC homology 1, basic leucine zipper transcription factor 2
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
BCL3
|
B-cell CLL/lymphoma 3
|
|
BCR
|
breakpoint cluster region
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
CCDC6
|
coiled-coil domain containing 6
|
|
CCNE2
|
cyclin E2
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CYLD
|
cylindromatosis (turban tumor syndrome)
|
|
EIF2S1
|
eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOXO3
|
forkhead box O3
|
|
FRS2
|
fibroblast growth factor receptor substrate 2
|
|
FUS
|
FUS RNA binding protein
|
|
FYN
|
FYN proto-oncogene, Src family tyrosine kinase
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
IFI16
|
interferon, gamma-inducible protein 16
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IKBKG
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
|
|
JUN
|
jun proto-oncogene
|
|
LAMTOR5
|
late endosomal/lysosomal adaptor, MAPK and MTOR activator 5
|
|
MAGEA11
|
melanoma antigen family A11
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPK9
|
mitogen-activated protein kinase 9
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCL
|
v-myc avian myelocytomatosis viral oncogene lung carcinoma derived homolog
|
|
NF2
|
neurofibromin 2 (merlin)
|
|
NFKB2
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100)
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
|
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
|
PAK2
|
p21 protein (Cdc42/Rac)-activated kinase 2
|
|
PKM
|
pyruvate kinase, muscle
|
|
PRKCA
|
protein kinase C, alpha
|
|
RARA
|
retinoic acid receptor, alpha
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RET
|
ret proto-oncogene
|
|
SET
|
SET nuclear proto-oncogene
|
|
SGK1
|
serum/glucocorticoid regulated kinase 1
|
|
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1
|
|
SKI
|
SKI proto-oncogene
|
|
SMAD3
|
SMAD family member 3
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STMN1
|
stathmin 1
|
|
TAL1
|
T-cell acute lymphocytic leukemia 1
|
|
TIAM1
|
T-cell lymphoma invasion and metastasis 1
|
|
TNS3
|
tensin 3
|
|
TP53
|
tumor protein p53
|
